Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-04-15
2008-04-15
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100
Reexamination Certificate
active
07358061
ABSTRACT:
Antibodies to a LAR phosphatase subunit, particularly antibodies having specificity to an intracellular domain of a phosphatase subunit, methods for generation thereof and cells producing these antibodies, and determination and examination methods of LAR/LAR derived molecules using these antibodies, as well as uses of these antibodies in diagnosis and therapy of thyroid cancer are disclosed.
REFERENCES:
patent: 4752583 (1988-06-01), Jensen
patent: 5538886 (1996-07-01), Schlessinger
patent: 5646333 (1997-07-01), Dobres
patent: 5736149 (1998-04-01), Avjioglu
patent: 5837505 (1998-11-01), Della-Cioppa
patent: 5888794 (1999-03-01), Schlessinger
patent: 5916561 (1999-06-01), Adolf
patent: 1 097 944 (2001-05-01), None
Brennan et al., J. Autoimmunity, 1989, 2 (suppl.): 177-186.
Zimmer, Cell Motility and the Cytoskeleton, 1991. 20:325-337.
Hell et al., Laboratory Investigation, 1995, 73: 492-496.
Fu et al., EMBO J., 1996, 15:4392-4401.
Vallejo et al., Biochimie, 2000 82:1129-1133.
Jang et al., Clinical Exp. Metastasis, 1997, 15: 469-483.
U.S. Appl. No. 09/743,492, Yamamoto et al.
Ahmad et al. “Functional Association Between the Insulin Receptor and the Transmembrane Protein-Tyrosine Phosphatase LAR in Intact Cells.”J Biol Chem., 272:448-57 (1997).
Ahmad et al. “Increased Abundance of the Receptor-Type Protein-Tyrosine Phosphatase LAR Accounts for the Elevated Insulin Receptor Dephosphorylating Activity in Adipose Tissue of Obese Human Subjects”J Clin Invest., 95:2806-12 (1995).
Bendayan, M., “Possibilities of False Immunocytochemical Results Generated by The Use of Monoclonal Antibodies: The Example of the Anti-proinsulin Antibody,”J. Histochem. Cytochem., 43:881-86 (1995).
Besco et al., “Genomic Organization and Alternative Splicing of the Human and Mouse RPTPp Genes,”BMC Genomics, 2:1-13 (2001).
Bost et al., “Antibodies against a peptide sequence within the HIV envelope protein crossreacts with human interleukin-2,” Immunol. Invest., 17(6-7):577-86 (1988).
Debant, et al., “The Multidomain Protein Trio Binds the LAR transmembrane Tyrosine Phosphatase, Contains a Protein Kinase Domain, and has Separate rac-specific and rho-specific Guanine Nucleotide Exchange Factor Domains,”Proc. Natl. Acad. Sci. U.S.A., 93:5466-71 (1996).
Faure et al., “Diagnostic Features of Primary Malignant Lymphomas of the Thyroid with Monoclonal Antibodies,”Cancer(Phila), 61:1852-1861 (1988).
Fernando et al., “Antibodies to the Human 2 Subunit of the GABAa/Benzodiazepine Receptors,”J. Neurochem., 64:1305-1311 (1995).
Furukawa et al. “Specific Interaction of the CD45 Protein-Tyrosine Phosphatase with Tyrosine-Phosphorylated CD3 zeta Chain”Proc Natl Acad Sci U S A., 91:10928-32 (1994).
Goldstein et al., “Regulation of Insulin Receptor Signaling by Protein-Tyrosine Dephosphorylation”,Receptor, 3:1-15(1993).
Hersh, et al., “The Salmonella Invasin SipB Induces Macrophage Apoptosis by Binding to caspase-1,”Proc. Natl. Acad. Sci. U.S.A., 96:2396-401 (1999).
Itoh et al., “Purification and Characterization of the Catalytic Domains of the Human Receptor-linked Protein Tyrosine Phosphatases HPTPβ, Leukocyte Common Antigen (LCA), and Leukocyte Common Antigen-related Molecule (LAR),”J. Biol. Chem., 267:12356-12363 (1992).
Kanemitsu, O., “Koutai Kougaku Nyuumon,” K.K. Chijin Shokan, 145-166 (1994).
Streuli et al. “A New Member of the Immunoglobulin Superfamily that has a Cytoplasmic Region Homologous to the Leukocyte Common Antigen”J Exp Med., 168:1523-30 (1988).
Streuli et al. “Distinct Functional Roles of the Two Intracellular Phosphatase Like Domains of the Receptor-linked Protein Tyrosine Phosphatases LCA and LAR,”EMBO J., 9:2399-407 (1990).
Streuli et al. “Expression of the Receptor-Linked Protein Tyrosine Phosphatase LAR: Proteolytic Cleavage and Shedding of the CAM-like Extracellular Region,”EMBO J., 11:897-907 (1992).
Supplemental European Search Report for EP 99 92 3958 dated Feb. 18, 2004.
Takeuchi et al., “Characterization of AE-6 Monoclonal Antibody Recognizing VHCSAGV Sequence in CD45 PTPase Domain,”Tissue Antigens, 42:441 (1993).
Yakura, “CD45 Isoforms and Functional Diversity of T and B Cells,”Med. Immunol., 27:333-339 (1994). (English translation of Table 1 of p. 334).
Yu et al., “The N-terminal and C-terminal Domains of a Receptor Tyrosine Phosphatase are Associated by Non-covalent Linkage,”Oncogene, 7:1051-1057 (1992).
Zhang et al., “LAR Tyrosine Phosphatase Receptor: Alternative Splicing is Preferential to the Nervous System, Coordinated with Cell Growth and Generates Novel Isoforms Containing Extensive CAG Repeats,”J. Cell Biol., 128:415-431 (1995).
Zhang, et al., “Molecular Cloning and Expression of a Unique Receptor-Like Protein-Tyrosine-Phosphatase in the Leukocyte-Common-Antigen-Related Phosphatase Family,” Biochem J., 302:39-47 (1994).
Konishi Noboru
Tsujikawa Kazutake
Uchino Yukiko
Yamamoto Hiroshi
Fuso Pharmaceutical Industries Ltd.
Halvorson Mark
Marshall & Gerstein & Borun LLP
Yu Misook
LandOfFree
Methods of diagnosing thyroid carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of diagnosing thyroid carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of diagnosing thyroid carcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2750165